Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network.
Saved in:
| Title: | Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network. |
|---|---|
| Authors: | Soardo F; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Spini A; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., L'Abbate L; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Bellitto C; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Pellegrini G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Ingrasciotta Y; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Paladin A; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., di Spazio L; Hospital Pharmacy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy., Campomori A; Hospital Pharmacy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy., Urru SAM; Hospital Pharmacy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy., Leoni O; Lombardy Regional Epidemiologic Observatory, Milan, Italy., Zanforlini M; Azienda Regionale per l'Innovazione E Gli Acquisti, S.p.A., Milan, Italy., Ancona D; Centro Regionale Farmacovigilanza, Regione Puglia, Bari, Italy., Stella P; Centro Regionale Farmacovigilanza, Regione Puglia, Bari, Italy., Cavazzana A; Azienda Zero, Regione Veneto, Padova, Italy., Scapin A; Azienda Zero, Regione Veneto, Padova, Italy., Lopes S; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy., Belleudi V; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy., Ledda S; Regione Autonoma della Sardegna, Cagliari, Italy., Carta P; Regione Autonoma della Sardegna, Cagliari, Italy., Rossi P; Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy., Ejlli L; Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy., Sapigni E; Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy., Puccini A; Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy., Trama U; Coordination of the Regional Health System, General Directorate for Health Protection, Naples, Italy., Bernardi FF; Coordination of the Regional Health System, General Directorate for Health Protection, Naples, Italy.; Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy., Mangano AMP; Agenzia Regionale Sanitaria della Regione Marche, Ancona, Italy., Balducci F; Agenzia Regionale Sanitaria della Regione Marche, Ancona, Italy., Spila-Alegiani S; Italian National Institute of Health, Rome, Italy., Massari M; Italian National Institute of Health, Rome, Italy., Alberti C; UOC Farmacia, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Krampera M; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine (DIMI), University of Verona, Verona, Italy., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy. |
| Source: | Expert opinion on biological therapy [Expert Opin Biol Ther] 2025 Nov; Vol. 25 (11), pp. 1241-1247. Date of Electronic Publication: 2025 Nov 05. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
